Literature DB >> 11386022

Frequency of the hemochromatosis C282Y and H63D mutations in a Polish population of Slavic origin.

D K Moczulski1, W Grzeszczak, B Gawlik.   

Abstract

BACKGROUND: Hereditary hemochromatosis is one of the most common monogenic diseases among Caucasians. The most frequent mutation causing hemochromatosis is C282Y in the HFE gene, the highest frequency of which has been observed in populations of Celtic origin. There are no studies providing information about the frequency of the C282Y and H63D mutations in the HFE gene in populations of Slavic origin.
MATERIAL AND METHODS: We collected 871 healthy unrelated subjects in Poland to assess the relevant frequencies. Each subject was genotyped for the C282Y and H63D mutations using a PCR-based protocol.
RESULTS: Among the analysed subjects 6.0% were CY heterozygotes, and only one person was YY homozygote. The observed frequency of the 282Y allele was 3.1%. The frequency of the D allele of the H63D polymorphism was 16.2%. There were 13 (1.5%) compound heterozygotes for C282Y and H63D found in the analysed group.
CONCLUSION: The high frequency of the Y allele in this Polish population of non-Celtic origin may indicate an early introduction of this mutation through admixture with a strong positive selection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11386022

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  8 in total

1.  Analysis of HFE genes C282Y, H63D, and S65D in patients with hyperferritinemia from northeastern Brazil.

Authors:  Gioconda Dias Rodrigues Leão; Juliana Mendonça Freire; Andrea Luciana Araújo Cunha Fernandes; Taissa Maria Moura de Oliveira; Nilma Dias Leão; Erica Aires Gil; Roberto Chaves de Vasconcelos; João Paulo da Silva Azevedo; Valéria Soraya de Farias Sales; Telma Maria de Araújo Moura Lemos; Marcos Dias Leão; Francisco Fernandes do Nascimento; James Farley Rafael Maciel; Rodrigo Villar de Freitas; Aldair de Souza Paiva; Geraldo Barroso Cavalcanti
Journal:  J Clin Lab Anal       Date:  2014-01-06       Impact factor: 2.352

2.  Lack of association of primary iron overload and common HFE gene mutations with liver cirrhosis in adult Indian population.

Authors:  Shalu Jain; Sarita Agarwal; Parag Tamhankar; Prashant Verma; Gourdas Choudhuri
Journal:  Indian J Gastroenterol       Date:  2011-08-06

3.  Unique frequencies of HFE gene variants in Roma/Gypsies.

Authors:  Dana Gabriková; Jarmila Bernasovská; Soňa Mačeková; Alexandra Bôžiková; Ivan Bernasovský; Alena Bališinová; Adriana Sovičová; Regína Behulová; Eva Petrejčíková; Miroslav Soták; Iveta Boroňová
Journal:  J Appl Genet       Date:  2012-02-22       Impact factor: 3.240

4.  Compound heterozygote (C282Y/H63D) of hereditary hemochromatosis in a 16-year-old girl with hypoplastic kidney.

Authors:  Barbara Kaczorowska-Hac; Katarzyna Sikorska; Krzysztof P Bielawski; Krystyna Schramm; Anna Balcerska
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

5.  Frequency of mutations related to hereditary haemochromatosis in northwestern Poland.

Authors:  Joanna Raszeja-Wyszomirska; Grzegorz Kurzawski; Janina Suchy; Iwona Zawada; Jan Lubinski; Piotr Milkiewicz
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

6.  Prevalence of 845G>A HFE mutation in Slavic populations: an east-west linear gradient in South Slavs.

Authors:  Grazyna Adler; Jeremy S Clark; Beata Łoniewska; Andrzej Ciechanowicz
Journal:  Croat Med J       Date:  2011-06       Impact factor: 1.351

7.  Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay.

Authors:  Marko Cukjati; Tomaz Vaupotic; Ruth Rupreht; Vladka Curin-Serbec
Journal:  BMC Med Genet       Date:  2007-11-23       Impact factor: 2.103

8.  The evolutionary adaptation of the C282Y mutation to culture and climate during the European Neolithic.

Authors:  Kathleen M Heath; Jacob H Axton; John M McCullough; Nathan Harris
Journal:  Am J Phys Anthropol       Date:  2016-01-22       Impact factor: 2.868

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.